Value Based and Patient Reported Outcomes David N. Assis, MD Assistant Professor of Medicine Yale University.

Slides:



Advertisements
Similar presentations
Research at The Royal Cornhill Hospital The Consequences of Trauma in Early Life For Adult Mental Health.
Advertisements

How does PROMIS compare to other HRQOL measures? Ron D. Hays, Ph.D. UCLA, Los Angeles, CA Symposium 1077: Measurement Tools to Enhance Health- Related.
PROMIS: The Right Place at the Right Time? David Cella, Ph.D. Department of Medical Social Sciences Northwestern University Chair, PROMIS Steering Committee.
15-minute Introduction to PROMIS Ron D. Hays, Ph.D UCLA Division of General Internal Medicine & Health Services Research Roundtable Meeting on Measuring.
Exercise and Cancer Outcomes Assoc Prof Sandi Hayes QUT, IHBI, School of Public Health.
A Clinician's Approach to Fatigue of Cancer Patients
Primary Sclerosing Cholangitis - Clinical Studies - Oslo U. Beuers Academic Medical Center, Univerity of Amsterdam, NL.
The emotional distress of children with cancer in China: An Item Response Analysis of C-Ped-PROMIS Anxiety and Depression Short Forms Yanyan Liu 1, Changrong.
FDA Approach to Review of Outcome Measures for Drug Approval and Labeling: Content Validity Initiative on Methods, Measurement, and Pain Assessment in.
Results Recruitment 507 out of 4417 patients were eligible to take part in the study 131 of them (25.5%) participated in the study Demographics Male-female.
Advances in PSC Research and Future Directions
PROMIS ® : Advancing the Science of PRO measurement Common Data Elements NIH CDE Webinar September 8, 2015 Ashley Wilder Smith, PhD, MPH Chief, Outcomes.
Development of Physical and Mental Health Summary Scores from PROMIS Global Items Ron D. Hays ( ) UCLA Department of Medicine
Introduction to the Patient-Reported Outcomes Measurement Information System (PROMIS) UCLA Center for East-West Medicine 2428 Santa Monica Blvd., Suite.
Positive and Negative Affect and Health in Lung Cancer Patients Jameson K. Hirsch, Ph.D. 1,2, H. Mason 1, & Paul R. Duberstein, Ph.D. 2 Department of Psychology,
Quality of Life CBMTG 0801 Investigators’ Meeting 07-Apr-2010.
Diversity and the Burden of Cancer David C. Momrow, M.P.H. Senior Vice President of Cancer Control American Cancer Society – Eastern Division January 21,
Item Response Theory (IRT) Models for Questionnaire Evaluation: Response to Reeve Ron D. Hays October 22, 2009, ~3:45-4:05pm
Considerations in Comparing Groups of People with PROs Ron D. Hays, Ph.D. UCLA Department of Medicine May 6, 2008, 3:45-5:00pm ISPOR, Toronto, Canada.
Promoting Patient Involvement in Medication Decisions David H. Hickam, MD, MPH Professor, Dept. of Medicine Oregon Health & Science University Portland,
Health-Related Quality of Life (HRQOL) Assessment in Outcome Studies Ron D. Hays, Ph.D. UCLA/RAND GCRC Summer Course “The.
Developing and Implementing Intervention Studies Using Geriatric Assessment Supriya Gupta Mohile, M.D., M.S. Assistant Professor of Medicine James Wilmot.
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
Comorbidity and Multimorbidity: Measurement and Interventions Holly M. Holmes, MD, MS Dept of General Internal Medicine.
Date of download: 9/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Palliative Care Intervention on Clinical.
Progress and future developments
Perceptions of a pharmacist in an ambulatory care setting
MEP Interest Group on Brain, Mind and Pain
Psychometric Evaluation of Items Ron D. Hays
NIH: Patient-Reported Outcomes Measurement Information System (PROMIS®) Ron D. Hays Functional Vision and Visual Function November 10, 2016, 8:55-9:15am.
Spartanburg Family Medicine Residency
Seeking Treatments for PSC Out of the Desert and into the Woods
Table 1: Patient Demographics
The long-term impact of psychotherapy in patients with refractory angina Patel PA2, Ali N1, Thapar S1, Sainsbury PA1 1Department of Cardiology, Bradford.
PATIENT ACTIVATION IN INFLAMMATORY BOWEL DISEASE PATIENTS
Liver transplantation and PSC
L.S. Remy1, G. Woody2, K. Lynch2, K. M. Kampman2
PROMIS-29 V2.0 Physical and Mental Health Summary Scores Ron D. Hays
New insights in the natural history of PSC
WG Mental Health Work Group Examination of Anxiety and Depression in Cameroon, Canada, India and the United States Islay Mactaggart Research Fellow in.
Protective Factors Screening
The Relationship Between Mental and Physical Health
THE APP THAT ALLOWS EVERY DOCTOR TO PRACTICE:
Clinical Correlates of Mental Health Issues in Outpatients with Inflammatory Bowel Disease under Routine Care Taryn Lores Health Psychologist, IBD Service.
Primary Sclerosing Cholangitis in Children
Basics of PSC Christopher L. Bowlus, MD
Liver Transplant For Patients with PSC
Eating Disorders Result in Different Eating Disorder Outcomes?
Oral Vancomycin as a Therapeutic Option for PSC
PSC Forum Veronica Miller, PhD Forum for Collaborative Research
Volume 144, Issue 3, Pages e7 (March 2013)
Physician / Patient Future Collaboration Opportunities
Primary Biliary Cholangitis
Caregivers Need Care Too
Mirela Anghelina, M.D., M.P.H.
Survivorship: Living Beyond Lung Cancer
Financial Disclosures
Outcomes in SCS Trials Ali Rezai MD.
Do Times Change?: Buffering Effects of Mindfulness for College Students and Older Adults   Briana Anderson, Amber Seidel, Chelom Leavitt, Kami Dvorakova,
Mean difference between treatment groups in the change from baseline for all PRO scores at months 1, 2 and 3. *Evaluable patients. Mean difference between.
China Patient‑centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study Design Jing Li, Rachel P Dreyer,
Rona Moss-Morris Professor of Psychology as Applied to Medicine
Solving Unknown Primary cancER (SUPER)
Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a critically appraised topic O.N. Kramer BS;1.
International Perthes Study Group
Evaluating the Significance of Individual Change
How to Measure Quality of Life
Patient-reported Outcome Measures
History of PSC Care Doctor, What’s Gonna Happen to Me?
Caregivers Need Care Too
Presentation transcript:

Value Based and Patient Reported Outcomes David N. Assis, MD Assistant Professor of Medicine Yale University

I have no disclosures relevant to this presentation.

Outline Value Based Medicine in PSC Patient Reported Outcomes (PRO) in PSC

Unmet Needs in PSC Surrogates Natural History Diagnostics Therapy Screening Surveillance Disease Mechanisms

Need for improved evidence! AASLD GuidelinesPBCPSC Year of latest guideline Recommendations (#)1536 Grade I33%17% Grade II33%61% Grade III33%22% Koh C, et al. Hepatology 2013;58:

Value

Value Based Medicine Healthcare Value = Outcome Cost Porter. N Engl J Med 2010; 363:

Value Based Medicine in PSC? How to define Value in PSC? – Rare disease – Heterogeneous phenotype – No proven effective therapy – Unclear Natural History – No current clinical trial endpoint Fabris et al. EASL 2015 [Abstract #1169].

Value Based Medicine in PSC? Collaboration of Italian Centers –University of Milan-Bicocca Selection of Outcome Indicators – Expert Consensus by Delphi Method Fabris et al. EASL 2015 [Abstract #1169].

Value Based Medicine in PSC? Proposed Outcome Indicators: –Mortality rate Those not yet listed for transplant –Death from cancer Bile duct, colon –Worsening of Osteoporosis –Rate of Cholangitis –Improvement in Quality of Life Fabris et al. EASL 2015 [Abstract #1169].

Value Based Medicine in PSC? Proposed Outcome Indicators: –Mortality rate Those not yet listed for transplant –Death from cancer Bile duct, colon –Worsening of Osteoporosis –Rate of Cholangitis –Improvement in Quality of Life Fabris et al. EASL 2015 [Abstract #1169].

–Short form 36 (SF-36) –Chronic liver disease questionnaire (CLDQ) –Fatigue impact scale –Hospital anxiety and depression scale –Patient health questionnaire –Mayo score –Psychological general well-being index –Fatigue impact scale Quality of Life in PSC

Learn from PBC! PBC-40 Tool –Patient-derived –Qualitative research –Item saturation –6 Domains Symptoms, Itch, Fatigue, Cognition, Social, Emotional Jacoby, et al. Gut 2005;54:1622–1629.

Patient Reported Outcome (PRO) A tool developed to directly measure the patient’s view of their health Iterative Process (takes time!) Development specific to the disease Allows for assessment of the effect of a medical intervention –Must show change over measurable time! FDA Guidance on PRO development

Patient Reported Outcome in PSC PSC is Heterogeneous –Multiple PSC Categories Large-Duct Small Duct IBD vs. no IBD –Early vs. late stage –Episodic nature of some symptoms –Age, gender, ethnic and cultural groups

Patient Reported Outcome in PSC A PRO in PSC will be useful if developed and tested on the demographic of interest North America Ethnically diverse Age range Disease range

Patient Reported Outcome in PSC Areas of Partnership between Patient Organizations and IPSCSG –Promotion of Patient Oriented Research –Development of a novel PRO Tool

Quality of Life in PSC PSC Partners Patient Registry (N=607) –Pruritus: 61% Average Intensity of (1-10) –Abdominal Pain: 64% Average intensity of (1-4) Safer, et al. Hepatology; 2015 AASLD Abstract #630.

Patient Reported Outcome in PSC Survey of PSC Partners Registry Patients Facebook comments (qualitative) March 2016 –Survey shared with FDA

Patient Reported Outcome in PSC April – May 2016 –Quantification of key symptoms via ATLAS Utilization of PROMIS ® tool format NIH Patient-Reported Outcomes Measurement Information System June 2016 –Follow up Survey to Registry Patients

450 participants 381 participants 69 participants excluded (incomplete data) PSC Partners Patient Registry: 850+

Questions With regard to your PSC, over the past month… Pain, Fever/Chills, Quality of Life, Isolation and Depression, Sleep, Anxiety and Worry, Itching, Fatigue

Pain With 0 being no abdominal pain and 10 being the worst abdominal pain imaginable, in the past month, I would rate my abdominal pain on average to be...

Fever and Chills In the past month I have felt chills and fevers Never 1- Rarely 2- Sometimes 3- Often 4- Always

Quality of Life In the past month, I would say my quality of life is Poor 2- Fair 3- Good 4- Very Good 5- Excellent

Isolation and Depression In the past month I found that things in my life were overwhelming... In the past month I felt emotionally exhausted Never 2- Rarely 3- Sometimes 4- Often 5- Always

Sleep In the past month my sleep was restful... In the past month stress disturbed my sleep Never 2- Rarely 3- Sometimes 4- Often 5- Always

Anxiety and Worry In the past month I felt anxious... In the past month I felt worried Never 2- Rarely 3- Sometimes 4- Often 5- Always

Pruritus In the past month, on a scale of 0-10 with 0 being no itch and 10 being maximum itching I would rate my itching right now as...

Pruritus Itching disturbed my sleep in the past month... I felt embarrassed because of the itching in the past month… 0- Never 1- Rarely 2- Sometimes 3- Often 4- Always 5- N/A

Fatigue In the past month my level of fatigue on most days was None 1- Mild 2- Moderate 3- Severe 4-Very severe

Fatigue In the past month I often felt run down... In the past month I often felt tired even when I have not done anything... In the past month I often was bothered by my fatigue Never 3- Rarely 3- Sometimes 4- Often 5- Always

PSC: with vs. without IBD 96 patients without IBD Patients with IBD reported more pain (p=0.0134)

PSC: Male vs. Female Female participants (N=190): Higher level of pain (p=0.001) More isolated (p=0.008) More helpless (p=0.0391) More emotionally exhausted (p=0.029) More upset (p=0.03) More itching interrupting sleep (p=0.017) More embarrassed itching (p=0.005) More run down (p=0.001) More fatigue (p=0.0241)

PSC: Caucasian vs. other races Other races (n=24): –More helpless (p=0.04) –More overwhelmed (p=0.01) –More emotionally exhausted (p=0.031) –More anxious (p=0.041) –More fatigue (p=0.04)

We need a PRO in PSC! –Understand and validate patient symptoms –Promote development of new Treatments that include Patient-Oriented Outcomes –Collaborative Process Patients and Patient Organizations International Centers Industry Partners FDA

Thank you Yale Liver Center Dr. Kim To Dr. Mario Strazzabosco Dr. James Boyer PSC Partners Seeking a Cure Rachel Gomel Ricky Safer Meegan Carey

Every Wall is a Door Ralph Waldo Emerson